Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 5 recruiting now small index

Aortic Valve Disease clinical trials

5 of 16 indexed Aortic Valve Disease trials are currently recruiting.

Corpus placement: #1,060 of 28,707 conditions by registered trial count.

16 US clinical trials · 5 currently recruiting · #1,060 of 28,707 conditions by registered trial count

Aortic Valve Disease: 16 US clinical trials tracked, 5 recruiting.

Aortic Valve Disease is the subject of 16 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. The most active sponsor is Abbott Medical Devices, running 2 of these trials.

Enrollment posture brief

Registry condition aortic-valve-disease

OPEN 5 | RECR 31% | LATE 0 | EARLY 0 | RANK #1060 | SPON 2

Nearest open-share peer: Depression, Postpartum (31% recruiting · 16 trials)

Adolescent62.5%Alcohol Intoxication56.3%AL Amyloidosis43.8%Aortic Valve Disease (this)31%Allergy18.8%
Open-enrollment share among volume-matched conditions near Aortic Valve Disease

Aortic Valve Disease lists 5 open slots (31% of 16 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Aortic Valve Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Aortic Valve Disease is recruiting below its size-band peers.

    5 of 16 indexed trials (31.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Aortic Valve Disease trials is spread across many organizations.

    Abbott Medical Devices accounts for 2 of 16 trials (12.5%). 14 distinct sponsors appear on at least one study for this condition label.

  3. Typical Aortic Valve Disease enrolment sits around 190 participants.

    Median target enrolment is 190 among the 16 trials that report a genuine target (sentinel values excluded). 6 of those (37.5%) plan for fewer than 100 participants.

  4. Aortic Valve Disease splits between interventional and observational designs.

    9 interventional and 7 observational studies make up this index (56.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Open and recent trials

16 total, page 1 of 1

RECRUITING 260 participants

Valved Graft PMCF Study

Abbott Medical Devices

NCT04754217

RECRUITING 225 participants

Prospective Long-Term Outcomes of a Standardized Ross Procedure

Baylor Research Institute

NCT06352671

RECRUITING NA 200 participants

CardioHeartConnect: Commercially Available Fitness for Cardiac Rehabilitation

University of Colorado, Denver

NCT07008911

RECRUITING NA 50 participants

The JenaValve ALIGN-AR LVAD Registry

JenaValve Technology

NCT06594705

RECRUITING NA 20 participants

Quantification of Debris Captured Using TCEP During VIV TAVR With BVF

Saint Luke's Health System

NCT05093764

ACTIVE NOT RECRUITING 3,000 participants

Pathogenetic Basis of Aortopathy and Aortic Valve Disease

Yale University

NCT03440697

ACTIVE NOT RECRUITING 1,000 participants

Identification of Genetic Causes of Calcific Aortic Valve Disease

Beth Israel Deaconess Medical Center

NCT04149600

ACTIVE NOT RECRUITING NA 532 participants

Evaluation of Safety and Effectiveness of the EMBLOK EPS During TAVR

Emblok

NCT05295628

ACTIVE NOT RECRUITING NA 190 participants

Avalus Ultra Post-Approval Study (PAS)

Medtronic Cardiac Surgery

NCT06506903

ACTIVE NOT RECRUITING NA 180 participants

The JenaValve ALIGN-AR Pivotal Trial

JenaValve Technology

NCT04415047

ACTIVE NOT RECRUITING 108 participants

Post Market Clinical Follow-Up Study in Patients Treated With the On-X Ascending Aortic Prosthesis (AAP)

JOTEC

NCT05082454

ACTIVE NOT RECRUITING NA 40 participants

Early Feasibility Study for the Foldax Tria Aortic Heart Valve

Foldax

NCT03851068

ACTIVE NOT RECRUITING NA 25 participants

J-Valve TF Early Feasibility Study

JC Medical, Inc., an affiliate of Edwards Lifesciences

NCT06034028

ACTIVE NOT RECRUITING 20 participants

SJM Masters HP 15mm Rotatable Mechanical Heart Valve as Aortic Valve Replacement Therapy

Abbott Medical Devices

NCT03924661

COMPLETED 273,365 participants

Optimizing Health Outcomes in Patients With Symptomatic Aortic Valve Disease

Duke University

NCT02266251

COMPLETED NA 40 participants

Optimization Post-TAVR to IMprove Activity Levels (OPTIMAL Study)

Johns Hopkins University

NCT06106451

Phase Distribution

Phase data not available

Named interventions

Most-linked intervention names on Aortic Valve Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

JenaValve Trilogy Heart Valve System Device
2 trials
Home-Based Activity Program plus Motivational Interviewing Intervention Behavioral
1 trials
Motivational Interviewing Intervention Behavioral
1 trials
Standard of Care plus Enhanced Patient Education Behavioral
1 trials
SENTINEL™ Cerebral Protection System Device
1 trials
EMBLOK™ Embolic Protection System ("EMBLOK EPS") Device
1 trials
Open repair Device
1 trials
Foldax Tria Aortic Valve Device
1 trials

US sites by state

Facility locations filed on Aortic Valve Disease trials. A trial with sites in several states counts in each.

Texas 7 trials
Michigan 6 trials
Ohio 5 trials
Illinois 5 trials
Georgia 5 trials
Pennsylvania 4 trials
New York 4 trials
Missouri 4 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Aortic Valve Disease page

16 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Aortic Valve Disease condition card totals 16 registered trials; most-linked intervention JenaValve Trilogy Heart Valve System; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.